|Bid||0.0000 x 39400|
|Ask||2.6000 x 43500|
|Day's Range||2.3200 - 2.4230|
|52 Week Range||2.2900 - 6.4000|
|Beta (3Y Monthly)||1.60|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 6, 2019 - May 10, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.33|
Gilead Sciences Inc., CVS Health Corp, Macerich Co. and OPKO Health Inc. have declined to their respective three-year lows
BioReference Laboratories, Inc., an OPKO Health Company (OPK), is pleased to announce it has been recognized by Forbes as one of America’s Best Large Employers of 2019. This list includes 500 large companies, and BioReference is one of only 15 companies in the Health Care Equipment and Services category to be selected for this designation. BioReference provides comprehensive laboratory testing to physicians, clinics, hospitals, employers, government entities, correctional institutions and medical groups.
The largest Insider Buys this week were for Hyster-Yale Materials Handling Inc., Kinder Morgan Inc., OPKO Health Inc. and Tradeweb Markets Inc.
MIAMI, April 12, 2019 -- OPKO Health, Inc. (NASDAQ: OPK) today reported additional results from the per protocol patient population from the Phase 2 dose escalation trial of.
OPKO Health Inc NASDAQ/NGS:OPKView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate and declining * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is moderate for OPK with between 5 and 10% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on April 1. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold OPK had net inflows of $2.87 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On the other...
How These Biotechnology Stocks Are Positioned in March(Continued from Prior Part)Analysts’ recommendations and target price Wall Street analysts expect an upside potential of 107.39% for Opko Health (OPK) based on the company’s closing price on
MIAMI, March 21, 2019 -- OPKO Health, Inc. (NASDAQ: OPK) today announced positive topline results from a Phase 2 dose escalation trial of OPK88003 to treat type 2 diabetes and.
OPKO Health (OPK) witnesses sluggishness in the Products revenues segment in Q4. However, contribution from RAYALDEE has been significant in the quarter.
OPKO Health Inc (NASDAQ:OPK) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018.
Premier Health Group (OTC:PHGRF) (CSE:PHGI), Aceto Corporation (ACET), OPKO Health Inc (OPK), and Midatech Pharma plc (NASDAQ:MTP) represent 4 healthcare stocks to pay attention to on Thursday. Premier Health Group (OTC:PHGRF) (CSE:PHGI) is a company which is laser-focused on developing innovative approaches that combine human skill-based expertise with state-of-the-art technologies to champion products and services meant to improve the quality of life for consumers. Premier Health Group (OTC:PHGRF) (CSE:PHGI) today announced the launch of at technology-enabled mental health counseling service for patients in urban centers and remote and underserved populations.
MIAMI, Feb. 27, 2019 -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2018. Business.
OPKO Health, Inc. (OPK) plans to announce its operating and financial results for the three and twelve months ended December 31, 2018 as well as provide guidance on expected revenues and operating expenses for the first quarter 2019 after the close of the U.S. financial markets on Wednesday, February 27, 2019. OPKO’s senior management will provide a business update and discuss its financial results in a live conference call and audio webcast beginning at 4:30 p.m. Eastern time on Wednesday, February 27, 2019. OPKO’s senior management will provide a business update and discuss results in greater detail in a conference call and live audio webcast at 4:30 p.m. Eastern time on Wednesday, February 27, 2019.
NEW YORK, Feb. 13, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.